We have demonstrated that CDK9 inhibitor AZD4573 exhibits the anti-tumor effect on breast cancer cells, inducing cell death through the accumulation of DNA damage caused by persistent T-R conflicts. This evidence concerns the gene CDK9 and breast cancer.